Lv72
4960 积分 2022-08-01 加入
The emerging safety profile of JAK inhibitors in rheumatic disease
5小时前
待确认
Targeting the JAK/STAT3/SOCS signaling pathway in Alzheimer's disease
5小时前
待确认
Microglial NLRP3 Inflammasomes in Alzheimer's Disease Pathogenesis: From Interaction with Autophagy/Mitophagy to Therapeutics
5小时前
待确认
Treatment with Interleukin-17A antibody restored behavioral and neuronal biomarkers in Amyloid-beta1‐–42-exposed model of Alzheimer's disease
6小时前
待确认
Systemic Amyloidosis due to Monoclonal Immunoglobulins: Cardiac Involvement
7天前
已完结
Systemic Amyloidosis due to Monoclonal Immunoglobulins
15天前
已完结
Efficacy and safety of iclepertin for cognitive impairment associated with schizophrenia (CONNEX programme): results from three phase 3 randomised controlled trials
24天前
已完结
Efficacy and safety of evenamide, a glutamate modulator, added to a second-generation antipsychotic in inadequately/poorly responding patients with chronic schizophrenia: Results from a randomized, double-blind, placebo-controlled, phase 3, international clinical trial
24天前
已完结
Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study
28天前
已完结
Efficacy, Tolerability, and Safety of TRPC4/5 Inhibitor BI 1358894 in Patients With Major Depressive Disorder and Inadequate Response to Antidepressants: A Phase 2 Randomized, Placebo-Controlled, Parallel Group, Dose-Ranging Trial
28天前
已完结
皖公网安备34019202002308
